Internal Medicine, Rheumatology · Salem, VA
NPI
1215936943
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1930 Braeburn Cir
Salem, VA, 24153
Phone (540) 772-3707
Medicare paid, 2024
$263K
12,367 services
Medicare patients, 2024
778
Average age 75
Drug cost, 2024
$2.4M
3,439 prescriptions
Company payments, 2025
$24.38
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Garry Bayliss was code J0897 (injection, denosumab, 1 mg), 7,680 times for 71 patients. In total Garry Bayliss billed 12,367 services in 29 codes, and Medicare paid $263K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 7,680 | 71 | $20.39 | $157K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 1,332 | 168 | $0.74 | $980 |
| 99214 Office E&M - Established | Office | 569 | 327 | $87.03 | $50K |
| 93010 Electrocardiogram | Facility | 338 | 260 | $5.99 | $2,024 |
| 99213 Office E&M - Established | Office | 250 | 178 | $61.52 | $15K |
| 20610 Joint Injection | Office | 193 | 119 | $50.95 | $9,833 |
| 96372 Injection Administration | Office | 131 | 76 | $11.08 | $1,451 |
| 20550 Musculoskeletal | Office | 89 | 59 | $35.67 | $3,175 |
| 99215 Office E&M - Established | Office | 54 | 38 | $122.88 | $6,636 |
| 99204 Office E&M - New | Office | 45 | 45 | $104.01 | $4,680 |
| 20600 Joint Injection | Office | 30 | 21 | $27.17 | $815 |
| 20605 Joint Injection | Office | 18 | 11 | $41.58 | $748 |
| 99203 Office E&M - New | Office | 13 | 13 | $75.42 | $980 |
| G0008 Administration of influenza virus vaccine | Office | 13 | 13 | $31.41 | $408 |
| 90653 Vaccine Product | Office | 12 | 12 | $81.82 | $982 |
By year: 2022 $282K for 14,765 services; 2023 $258K for 12,937 services; 2024 $263K for 12,367 services.
Medicare prescription drug claims, 2024
In 2024, the drug Garry Bayliss prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 593 prescriptions and refills. In total Garry Bayliss wrote 3,439 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 593 | 1,408 | 167 | $16K |
| Hydroxychloroquine Sulfate Generic | 344 | 806 | 109 | $12K |
| Prednisone Generic | 334 | 638 | 104 | $2,685 |
| Meloxicam Generic | 150 | 246 | 34 | $493 |
| Tramadol Hcl Generic | 134 | 134 | 21 | $511 |
| Gabapentin Generic | 130 | 194 | 31 | $1,813 |
| Celecoxib Generic | 112 | 195 | 31 | $2,828 |
| Duloxetine Hcl Generic | 104 | 214 | 21 | $1,940 |
| Folic Acid Generic | 103 | 252 | 25 | $775 |
| Allopurinol Generic | 78 | 229 | 27 | $839 |
| Nabumetone Generic | 76 | 119 | 17 | $901 |
| Humira(Cf) Pen Adalimumab | 74 | 74 | 11 | $519K |
| Sulfasalazine Dr Sulfasalazine | 72 | 198 | 22 | $4,901 |
| Sulfasalazine Generic | 71 | 183 | 22 | $2,341 |
| Leflunomide Generic | 70 | 151 | 25 | $4,167 |
Brand drugs: - claims; generic drugs: 2,963 claims; opioid claims: 144.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Garry Bayliss $24.38 ($24.38 in general payments such as food, travel and fees) from 1 company. The largest payer was Novartis Pharmaceuticals Corporation with $24.38.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 1 | $24.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.